[Rosai-Dorfman-Destombes disease with a misleading laryngeal presentation].
Une maladie de Rosai–Dorfman–Destombes de présentation laryngée trompeuse.
Acute respiratory distress
Détresse respiratoire aiguë
Larynx
Maladie de Rosai–Dorfman–Destombes
Rosai–Dorfman–Destombes disease
Journal
Annales de pathologie
ISSN: 0242-6498
Titre abrégé: Ann Pathol
Pays: France
ID NLM: 8106337
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
received:
12
10
2021
revised:
01
03
2022
accepted:
03
03
2022
pubmed:
30
8
2022
medline:
27
10
2022
entrez:
29
8
2022
Statut:
ppublish
Résumé
Rosai-Dorfman-Destombes disease is a rare non-Langerhansian cell histiocytosis characterized by the accumulation of large activated histiocytes in the affected tissues with images of emperipolesis. The diagnosis is not really problematic in the classical forms, with a lymph node presentation, whose histology is very suggestive. However, it can be much more difficult in the extra-nodal forms, which are misleading in both their clinical and histological presentation. We report here a case illustrating this diagnostic difficulty. Firstly, clinically, the disease was revealed by an unusual laryngeal location, responsible for acute obstructive respiratory distress and requiring urgent surgical management. Secondly, histologically, the diagnosis was not evoked in the first instance by analysis of the laryngeal lesion. Indeed, there was a not specific appearing polymorphic infiltrate, associating small lymphocytes, plasma cells and numerous histiocytes, without evidence for a lymphoma after immunohistochemistry and lymphocyte clonality analysis. However, after re-examination of the slides, the histiocytes sometimes appeared large or xanthomised and have a PS100+, CD1a-, langerhine- phenotype, with rare images of emperipolesis. These aspects finally suggested the diagnosis of Rosai-Dorfman-Destombes disease, then confirmed by a cervical lymph node biopsy showing characteristic histological features. Simultaneously, NGS analysis of the laryngeal lesion showed a mutation in the MAP2K1 gene, in accordance with the diagnosis. The patient was treated with revlimid and dexamethasone for 6 months, with complete remission, and is currently undergoing maintenance treatment with revlimid.
Identifiants
pubmed: 36038429
pii: S0242-6498(22)00061-X
doi: 10.1016/j.annpat.2022.03.002
pii:
doi:
Substances chimiques
Lenalidomide
F0P408N6V4
Dexamethasone
7S5I7G3JQL
Types de publication
English Abstract
Journal Article
Langues
fre
Sous-ensembles de citation
IM
Pagination
475-480Informations de copyright
Copyright © 2022 Elsevier Masson SAS. All rights reserved.